Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Statistics

Total Valuation

MCRB has a market cap or net worth of $140.95 million. The enterprise value is $183.00 million.

Market Cap	140.95M
Enterprise Value	183.00M

Important Dates

The next confirmed earnings date is Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

MCRB has 8.75 million shares outstanding. The number of shares has increased by 21.08% in one year.

Current Share Class	8.75M
Shares Outstanding	8.75M
Shares Change (YoY)	+21.08%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	11.15%
Float	6.46M

Valuation Ratios

The trailing PE ratio is 1.64.

PE Ratio	1.64
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.28
P/TBV Ratio	4.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.13
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.65.

Current Ratio	1.57
Quick Ratio	1.50
Debt / Equity	2.65
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-29.57%
Return on Invested Capital (ROIC)	-55.97%
Return on Capital Employed (ROCE)	-97.57%
Revenue Per Employee	n/a
Profits Per Employee	$834,621
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.84% in the last 52 weeks. The beta is 0.20, so MCRB's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+2.84%
50-Day Moving Average	18.63
200-Day Moving Average	13.93
Relative Strength Index (RSI)	34.59
Average Volume (20 Days)	92,047

Short Selling Information

The latest short interest is 798,666, so 9.12% of the outstanding shares have been sold short.

Short Interest	798,666
Short Previous Month	858,372
Short % of Shares Out	9.12%
Short % of Float	12.36%
Short Ratio (days to cover)	6.09

Income Statement

Revenue	n/a
Gross Profit	-9.20M
Operating Income	-110.12M
Pretax Income	-53.85M
Net Income	85.97M
EBITDA	-105.50M
EBIT	-110.12M
Earnings Per Share (EPS)	$10.22

Balance Sheet

The company has $45.38 million in cash and $87.43 million in debt, giving a net cash position of -$42.06 million or -$4.80 per share.

Cash & Cash Equivalents	45.38M
Total Debt	87.43M
Net Cash	-42.06M
Net Cash Per Share	-$4.80
Equity (Book Value)	32.95M
Book Value Per Share	3.76
Working Capital	17.75M

Cash Flow

In the last 12 months, operating cash flow was -$59.94 million and capital expenditures -$434,000, giving a free cash flow of -$60.38 million.

Operating Cash Flow	-59.94M
Capital Expenditures	-434,000
Free Cash Flow	-60.38M
FCF Per Share	-$6.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.08%
Shareholder Yield	-21.08%
Earnings Yield	60.99%
FCF Yield	-42.83%

Analyst Forecast

The average price target for MCRB is $14.33, which is -10.99% lower than the current price. The consensus rating is "Hold".

Price Target	$14.33
Price Target Difference	-10.99%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Apr 22, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2